Skip to main content
HOWL filings

Corporate insider profile

Luke Evnin Filing Activity

Latest reported as Director of Werewolf Therapeutics, Inc. (HOWL).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,085,613.32
Latest transaction
Jun 9, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 9, 2026Werewolf Therapeutics, Inc. (HOWL)DirectorSale76,928$0.37$28,463
Jun 8, 2026Werewolf Therapeutics, Inc. (HOWL)DirectorSale105,565$0.41$43,028
Jun 3, 2026Werewolf Therapeutics, Inc. (HOWL)DirectorSale139,803$0.46$63,624